VeraChem offers a suite of advanced computational tools designed for drug discovery and molecular modeling. Their products include VConf, which facilitates the conversion of 2D small molecules to 3D structures while ensuring low-energy conformers and enforcing stereochemistry. VCharge provides rapid access to accurate partial atomic charges for drug-like compounds, enhancing modeling and quantitative structure-activity relationship (QSAR) applications. Additionally, VM2 calculates protein-ligand binding affinities using mining-minima free energy methods, while VDock enables fast protein-ligand docking with a user-friendly graphical interface. Other tools like VDraw, VMap, and VDisplay support intuitive chemical drawing, ligand superposition, and molecular visualization, respectively.

The technologies developed by VeraChem emphasize accuracy and efficiency in molecular modeling. VCharge, for instance, employs an electronegativity equalization method to derive partial charges that closely match those obtained from more computationally intensive methods, such as Hartree-Fock calculations. This tool is optimized for a wide range of drug-like compounds and is compatible with popular force fields like AMBER and CHARMM. Furthermore, the integration of tools like VFilter and Vrms allows for the analysis and comparison of molecular conformers, ensuring that researchers can effectively manage and interpret complex molecular data. Overall, VeraChem's technologies are designed to streamline the drug discovery process while maintaining high standards of accuracy and usability.

United States

VERACHEM LLC is a biotechnology company based out of P.O. BOX 2206, GERMANTOWN, Maryland, United States.

VeraChem

Company Details